ARA-290 (Cibinetide)

Global Peptide Sciences supplies ARA-290 to laboratories across Australia, supporting studies into innate repair receptor signalling, neuroprotection and tissue-protective research pathways.

ARA-290, known by its international nonproprietary name cibinetide, is an 11 amino acid peptide modelled on the helix-B region of erythropoietin. Unlike erythropoietin itself, it was engineered to selectively activate the innate repair receptor, a heteromeric complex formed by the erythropoietin receptor and CD131, rather than the classical receptor pathway responsible for red blood cell production.

Each batch is produced under controlled manufacturing conditions and undergoes independent laboratory verification, supporting consistent, repeatable results across analytical testing. A Certificate of Analysis is available on request for every order.

What Is ARA-290 Peptide?

Many researchers ask what is ARA-290 peptide and how it differs from the erythropoietin molecule it was derived from.

By targeting the innate repair receptor rather than the classical erythropoietin receptor, ARA-290 has been studied for tissue-protective and anti-inflammatory signalling without the erythropoietic activity, and associated red blood cell effects, seen with full-length erythropoietin. This selective receptor profile is what distinguishes ara 290 peptides from earlier EPO-derived research compounds, and why it appears across neuroprotection and inflammatory signalling literature specifically.

ARA-290 Peptide Benefits in Research

Within controlled laboratory settings, research connected to ara 290 peptide benefits commonly looks at areas such as:

• Innate repair receptor signalling research
• Neuropathic pain and peripheral nerve models
• Anti-inflammatory pathway studies
• Small nerve fibre regeneration research

These points reflect laboratory and clinical trial observation only and are not intended as claims about therapeutic outcomes for any individual.

Research Areas of Interest

• Studies into small fibre neuropathy models
• Investigation of spinal microglial activation pathways
• Comparative research against erythropoietin receptor signalling
• Tissue-protective and cellular stress response research

Product Information

Compound: ARA-290 (Cibinetide)

Classification: Synthetic 11 amino acid peptide, erythropoietin helix-B derived

Form: Lyophilised powder

Purity level: 99% or above (HPLC / MS verified)

Testing: Independent third-party laboratory verification, CoA available on request

Storage: Store at -20°C

ARA-290 Reconstitution

Researchers carrying out ARA-290 reconstitution for laboratory use typically follow standard laboratory protocols for combining lyophilised peptides with an appropriate sterile diluent prior to further analytical handling. Global Peptide Sciences does not provide reconstitution instructions intended for self-administration, and all reconstitution should be carried out in accordance with your own laboratory’s established procedures and safety documentation.

Why Researchers Choose ARA-290

Laboratories examining innate repair receptor signalling frequently reference ARA-290 because, unlike many research peptides, it has progressed through Phase 2 human trials rather than remaining purely preclinical. Published trials in sarcoidosis-associated small fibre neuropathy reported objective corneal nerve fibre regeneration alongside changes in reported pain, while separate work in type 2 diabetic neuropathy produced more mixed findings. The compound has received orphan drug and fast track designations from regulators in some jurisdictions, though it has not completed Phase 3 trials and is not approved as a medicine anywhere, including Australia.

Researchers comparing options across related recovery-focused compounds can explore the full healing and recovery research category for additional research materials.

Buy ARA-290 in Australia

Researchers looking to buy ARA-290 Australia can access verified, batch-tested material through Global Peptide Sciences, with independent Certificates of Analysis available for every order.

Laboratories searching for ara 290 peptide or ara 290 peptides more generally, or asking about ara 290 in Australia specifically, can rely on a consistent supply chain backed by HPLC and LC-MS verification. Researchers can review product-specific documentation directly before finalising an order.

Global Peptide Sciences offers consistent quality control at every stage of supply, and researchers can browse the full catalogue to view other research compounds available alongside ARA-290.

Research Use Only

This compound is supplied strictly for laboratory research purposes and is not approved for human consumption or therapeutic use.